Rimeporide in Duchenne presented at the 5th Myology Congress
EspeRare will present a poster on the "Translational Development of Rimeporide, a Sodium-Hydrogen Exchanger (NHE-1) Inhibitor, as a therapy for Patients with Duchenne Muscular Dystrophy" at the 5th Myology International Confenrence in Lyon from 14th to 18th March 2016.
Click on picture to view
For more information on the Myology Congress click here
As a private non-for-profit organisation, we strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drugs to reach these underserved patients.